Managing diabetes in patients with diabetes of long duration.

Curtis L Triplitt

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE: The purpose of this article is to review clinical issues related to the management of hyperglycemia in older patients with diabetes of long duration. CONCLUSION: Older adults represent an extensive proportion of patients with type 2 diabetes. Treatment goals need to be individualized to take into account comorbid conditions, life expectancy, diabetes complications, and the benefits of glycemic control. For both older patients and especially those with chronic renal insufficiency, the most important drug-related adverse effect to avoid is hypoglycemia, and avoidance of any severe hypoglycemia should be paramount. Patients with long duration of diabetes are often treated with insulin. Recent data show that glucagon-like peptide-1 receptor agonists may be used in combination with insulin for patients not achieving glycemic goals, with reductions in the doses of insulin used and with a low risk of hypoglycemia and possible weight loss.

Original languageEnglish (US)
JournalThe Diabetes Educator
Volume38
Issue number4 Suppl
StatePublished - Jul 2012

Fingerprint

Hypoglycemia
Insulin
Diabetes Complications
Life Expectancy
Chronic Renal Insufficiency
Hyperglycemia
Type 2 Diabetes Mellitus
Weight Loss
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Managing diabetes in patients with diabetes of long duration. / Triplitt, Curtis L.

In: The Diabetes Educator, Vol. 38, No. 4 Suppl, 07.2012.

Research output: Contribution to journalArticle

Triplitt, Curtis L. / Managing diabetes in patients with diabetes of long duration. In: The Diabetes Educator. 2012 ; Vol. 38, No. 4 Suppl.
@article{5ce76194015e46658d753be62ccfd9ed,
title = "Managing diabetes in patients with diabetes of long duration.",
abstract = "PURPOSE: The purpose of this article is to review clinical issues related to the management of hyperglycemia in older patients with diabetes of long duration. CONCLUSION: Older adults represent an extensive proportion of patients with type 2 diabetes. Treatment goals need to be individualized to take into account comorbid conditions, life expectancy, diabetes complications, and the benefits of glycemic control. For both older patients and especially those with chronic renal insufficiency, the most important drug-related adverse effect to avoid is hypoglycemia, and avoidance of any severe hypoglycemia should be paramount. Patients with long duration of diabetes are often treated with insulin. Recent data show that glucagon-like peptide-1 receptor agonists may be used in combination with insulin for patients not achieving glycemic goals, with reductions in the doses of insulin used and with a low risk of hypoglycemia and possible weight loss.",
author = "Triplitt, {Curtis L}",
year = "2012",
month = "7",
language = "English (US)",
volume = "38",
journal = "Diabetes Educator",
issn = "0145-7217",
publisher = "SAGE Publications Inc.",
number = "4 Suppl",

}

TY - JOUR

T1 - Managing diabetes in patients with diabetes of long duration.

AU - Triplitt, Curtis L

PY - 2012/7

Y1 - 2012/7

N2 - PURPOSE: The purpose of this article is to review clinical issues related to the management of hyperglycemia in older patients with diabetes of long duration. CONCLUSION: Older adults represent an extensive proportion of patients with type 2 diabetes. Treatment goals need to be individualized to take into account comorbid conditions, life expectancy, diabetes complications, and the benefits of glycemic control. For both older patients and especially those with chronic renal insufficiency, the most important drug-related adverse effect to avoid is hypoglycemia, and avoidance of any severe hypoglycemia should be paramount. Patients with long duration of diabetes are often treated with insulin. Recent data show that glucagon-like peptide-1 receptor agonists may be used in combination with insulin for patients not achieving glycemic goals, with reductions in the doses of insulin used and with a low risk of hypoglycemia and possible weight loss.

AB - PURPOSE: The purpose of this article is to review clinical issues related to the management of hyperglycemia in older patients with diabetes of long duration. CONCLUSION: Older adults represent an extensive proportion of patients with type 2 diabetes. Treatment goals need to be individualized to take into account comorbid conditions, life expectancy, diabetes complications, and the benefits of glycemic control. For both older patients and especially those with chronic renal insufficiency, the most important drug-related adverse effect to avoid is hypoglycemia, and avoidance of any severe hypoglycemia should be paramount. Patients with long duration of diabetes are often treated with insulin. Recent data show that glucagon-like peptide-1 receptor agonists may be used in combination with insulin for patients not achieving glycemic goals, with reductions in the doses of insulin used and with a low risk of hypoglycemia and possible weight loss.

UR - http://www.scopus.com/inward/record.url?scp=84871685733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871685733&partnerID=8YFLogxK

M3 - Article

C2 - 22661393

AN - SCOPUS:84871685733

VL - 38

JO - Diabetes Educator

JF - Diabetes Educator

SN - 0145-7217

IS - 4 Suppl

ER -